Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emerald Health Therapeutics Inc (OP: EMHTF )

N/A UNCHANGED
Last Price Updated: 3:42 PM EST, Nov 11, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Emerald Health Therapeutics Inc

< Previous 1 2 Next >
Emerald Health Therapeutics and Skye Bioscience Close Plan of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.
San Diego, California--(Newsfile Corp. - September 30, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical... 
Via Newsfile
Topics Derivatives
Exposures Derivatives
The Canadian Cannabis Report - Monday, Sept. 12
The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
Emerald Health Therapeutics, Inc. Reports 2022 Q2 Results
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or... 
Via Newsfile
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company")... 
Via Newsfile
HYTN Awarded Medical Cannabis Sales License By Health Canada
HYTN Cannabis Inc., wholly owned subsidiary of HYTN Innovations Inc. (CSE:HYTN) has been awarded a license by Health Canada allowing for the sale of cannabis for medical purposes. 
Via Benzinga
Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Regulatory Compliance
Exposures Legal Regulatory
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, July 4
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, June 20
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
Skye Bioscience Signs Arrangement Agreement With Emerald Health Therapeutics, Here Are The Details
Skye Bioscience, Inc. (OTCQB: SKYE) and Emerald Health Therapeutics, Inc. 
Via Benzinga
Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
Arrangement is expected to fund Skye's proprietary synthetic cannabinoid-derivative therapeutic initially targeting glaucoma for first Phase 2 clinical study planned to... 
Via Newsfile
Topics Derivatives
Exposures Derivatives
The Canadian Cannabis Report - Monday, March 28
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
HYTN Innovations To Accept Cannabis Orders Directly From Provinces & Territories
HYTN Innovations Inc. (CSE:HYTN) announced that it has 
Via Benzinga
The Canadian Cannabis Report - Monday, Mar. 7
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
HYTN Innovations Receives Health Canada's Approval To Sell Cannabis
HYTN Innovations Inc.’s (CSE:HYTN) subsidiary H... 
Via Benzinga
Emerald Health Therapeutics Sells Patents to FlowerPod
Vancouver, British Columbia--(Newsfile Corp. - January 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered... 
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
The Canadian Cannabis Report - Monday, Jan. 3
The past, present, and future of the Canadian cannabis sector based on the MCCCI, which is a proprietary 22 stock index. 
Via Talk Markets
The Canadian Cannabis Report- Monday, Dec. 27
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
The Canadian Cannabis Report- Monday, Dec. 20
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
Emerald Health Therapeutics Leaving 'Saturated' Cannabis Market, Will Focus On Pharmaceuticals
Emerald Health Therapeutics, Inc. (CSE:EMH) (OTCQX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Exposures COVID-19 Cannabis
The Canadian Cannabis Report: There Were No Stocks That Increased By More Than 10%
The past, present and future performance of the Canadian cannabis sector based on the MCCCI, which is a index of 22 stocks. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics and HYTN Cannabis to Launch Cannabis Beverages in Canada
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") and... 
Via Newsfile
Topics Cannabis Supply Chain
Exposures COVID-19 Cannabis Supply Chain
Emerald Health's Partner, Flower Pod, Launches Unique Dose-Controlled Cannabis Vaporizer
Emerald Health Therapeutics, Inc. (CSE:EMH) (OTCQX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announces that... 
Via Newsfile
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Emerald Health Therapeutics Announces Chief Financial Officer Transition
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today... 
Via Newsfile
Topics Cannabis Supply Chain
Exposures COVID-19 Cannabis Supply Chain
Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released... 
Via Newsfile
Topics Cannabis Intellectual Property Product Recall
Exposures COVID-19 Cannabis Intellectual Property
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.